Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Citizens has reaffirmed a Market Outperform rating and an $825.00 price target on Axon Enterprise (NASDAQ: AXON), saying investor skepticism around AI has weighed on the stock despite the company’s robust fundamentals and recent quarterly outperformance. The firm highlighted Axon’s combination of physical devices, software and customer trust as pos…
Citizens has reiterated its Market Outperform rating on AxoGen, Inc. and maintained a $42.00 price target after the company reported quarterly revenue of $59.9 million and adjusted EPS of $0.07, both ahead of consensus. The quarter included roughly $9.1 million of one-time expenses tied to the BLA approval of Avance, and Citizens expects continued …
Morgan Stanley reduced its free cash flow-based price target for IBM to $247 from $304 while retaining an Equalweight rating, citing AI disruption risk after the Claude Code tool announcement. The firm noted acute volatility across software and services peers, adjusting its outlook amid a roughly 20% share decline over the past month and 22% year-t…
Citizens reiterated a Market Outperform rating on American Tower (AMT) and sustained a $260 price target, highlighting the stock's valuation on a 2026 adjusted funds from operations (AFFO) basis and a robust dividend profile. The firm contrasted the infrastructure REIT's predictable cash flows with higher-risk AI-related names, while noting mixed v…
Citizens maintained a Market Outperform rating on Addus HomeCare (ADUS) and left its 2026-2027 EBITDA forecasts unchanged, assigning a $150.00 price target. The firm flagged both acquisition potential and organic growth drivers, while Addus reported better-than-expected fourth-quarter 2025 results but saw its stock fall in after-hours trading.
Citizens reaffirmed a Market Perform rating on Avanos Medical (AVNS), leaving its 2027 EPS estimate at $1.25 and valuing the stock at roughly 11 times that estimate. The analyst house pointed to meaningful progress in 2025 - led by SNS business improvements, operating efficiency, capital allocation, and portfolio optimization - but said some commer…
Deutsche Bank reduced its recommendation on Beiersdorf AG (OTC: BDRFY) from Buy to Hold on Wednesday while keeping a EUR105.00 price target. The bank cited the stock’s recent relative strength and valuation metrics - including elevated P/E multiples and forward pricing that appear to bake in consumer like-for-like growth - as the rationale for the …
China announced it has met obligations tied to the U.S. Section 301 trade statute and urged Washington not to pursue further punitive measures, after the U.S. Trade Representative indicated ongoing investigations that could result in more tariffs. Beijing said it prefers to resolve issues through existing economic and trade consultation channels bu…
Zimbabwe has ended negotiations on a proposed $367 million bilateral health Memorandum of Understanding with the United States, saying the terms would have required prolonged sharing of biological resources and epidemiological data without guarantees of access to resulting medical innovations. The U.S. embassy said it will wind down health support.…
U.S. stock index futures ticked higher on Wednesday after a period of volatility as investors digested mixed signals about the economic impact of rapid AI investment and navigated ongoing uncertainty over newly announced tariffs. Nvidia’s quarterly results, due after the close, were the focal point for investors seeking confirmation that surging ca…
JP Morgan raised its long-term gold price forecast by 15% to $4,500 an ounce while maintaining a year-end 2026 projection of $6,300. The bank attributed the revision to stronger-than-expected central bank buying, official statements about U.S. Treasury divestment and a trend of some countries moving revenues from the dollar into the Chinese renminb…
UBS initiated coverage of CEVA Inc. (NASDAQ:CEVA) with a buy rating and a $27.00 price target, implying roughly 34% upside from the stock's current $20.13 level. The research note points to CEVA's dominant wireless and connectivity IP position, high gross margins, and a nascent but accelerating edge AI royalty stream as drivers of valuation expansi…
President Volodymyr Zelenskiy said Ukrainian negotiators will meet U.S. officials on Thursday to discuss a post-war reconstruction plan dubbed the "prosperity package," preparations for a trilateral meeting that would include Russia, and arrangements for prisoner exchanges. The meeting in Geneva will bring Ukraine's chief negotiator together with U…
Utz Brands looks cheap relative to the market when you consider its brand portfolio and potential uplift from a targeted California expansion. With revenue momentum in branded snacks and a sub-$1.4B market cap, this trade aims to capture share gains and margin improvement over the next 45 trading days while keeping risk controlled.
ASML's 2025 annual report states that the artificial intelligence surge has become the principal source of demand for its lithography systems. The company cites broad-based capacity build-up across its customer base, anticipates continued semiconductor market growth led by AI logic and memory, notes evolving export controls including new Dutch meas…
Fiserv has been through a brutal 2025, but recent quarterly beats, a clearer management plan and bargain valuation metrics create an asymmetric risk/reward. This trade targets recovery as the company converts stabilization into organic growth and margin expansion.
Indian equity benchmarks closed modestly higher as gains in metals, automotive and technology stocks offset weakness in select heavyweight names. The Nifty 50 rose 0.23% at the close, while the BSE Sensex 30 recorded a smaller advance of 0.06%. Market breadth was mixed and implied volatility fell, while commodities and currency pairs showed modest …
Hong Kong private home prices rose 0.5% in January, marking an eighth consecutive month of gains and reinforcing signs of a market recovery. Analysts at major banks have lifted their 2026 growth forecasts, with forecasts ranging from about 10% to 15%, while developers and the government have exhibited greater activity and policy support for the hou…
On Running has opened a robot-operated factory in Busan, South Korea, expanding its automated manufacturing footprint to accelerate production and delivery. The move reflects a broader push toward nearshoring in response to U.S. tariff hikes, supply-chain disruption and geopolitical risk. The Busan plant uses a spray-on process for uppers and can p…
Global equity demand remained sturdy in February, with $101 billion of inflows, but Barclays strategists warn that a shift in the AI narrative - from build-out enthusiasm to concern about rapid disruption and possible deflation - is altering positioning across markets. Hedge funds and systematic managers have trimmed exposure, retail sentiment has …
Reddit beat Q4, showed 70% revenue growth to $726M and announced enterprise partnerships. Technicals are attractive and fundamentals support a case that AI-driven enterprise and ad products could meaningfully widen monetization. This trade idea presents a long entry, stop-loss and target for a 180-trading-day horizon with balanced risks.
<p>Fresh Del Monte (FDP) is trading near its 52-week high but the underlying data — improving margins, strong free cash flow, and a lightweight balance sheet — argue the company still has room to re-rate. This trade idea lays out a mid-term long with an entry at current levels, a stop under the 50-day moving average, and a pragmatic upside target d…
GSK has agreed to acquire Canada-based 35Pharma for $950 million, incorporating a cardiopulmonary drug candidate, HS235, into its pipeline. The acquisition is described by the companies as complementary to GSK's push into conditions associated with obesity and is one of several deals pursued under CEO Luke Miels to bolster the company’s drug portfo…
Wells Fargo has opened coverage of Live Nation Entertainment with an overweight rating and a $204.00 price target, emphasizing the companys strategic evolution from concert promoter to owner-operator of venues. The bank forecasts substantial revenue and adjusted operating income contributions from the venue business by 2026 and models outsized retu…
Aston Martin said it will reduce its global workforce by as much as one-fifth to secure roughly 40 million pounds of annualised savings as the luxury carmaker grapples with the financial impact of U.S. import tariffs and weak sales in China. The company also trimmed its five-year capital expenditure plan and sold perpetual Formula One branding righ…
